Table 3.

Partial correlations of TBS prior to adalimumab (baseline) and after 6 months of TNF-α blockade, in 29 patients with moderate to-severe psoriasis^∗.

Variable	Trabecular bone score (TBS)
	Baseline		6 months
	r	p	r	p
HOMA	−0.203	0.32	−0.445	0.02
QUICKI	0.240	0.24	0.497	0.01
Systolic BP	−0.424	0.03	−0.407	0.04
Diastolic BP	−0.455	0.02	−0.455	0.03
Total cholesterol	−0.097	0.64	−0.022	0.92
HDL cholesterol	0.345	0.08	0.276	0.17
LDL cholesterol	−0.220	0.28	−0.120	0.56
Triglycerides	−0.176	0.39	−0.130	0.53
Non-HDL cholesterol	−0.246	0.23	−0.141	0.49
Apo-A1	0.189	0.37	0.203	0.32
Apo-B	−0.190	0.36	−0.145	0.48
Lpa	0.100	0.63	0.216	0.30
Castelli index	−0.411	0.04	−0.329	0.10
Apo-B/Apo-A1	−0.295	0.15	−0.060	0.77
Homocysteine	0.179	0.43	0.055	0.78
ESR	0.093	0.65	−0.024	0.91
HbA1c	−0.330	0.09	0.025	0.91
Insulin	−0.214	0.29	−0.477	0.01
Glucose	−0.227	0.27	−0.180	0.38
Creatinine	0.292	0.15	0.004	0.98
hs-CRP	−0.424	0.03	−0.483	0.01
Weight	−0.532	0.005	−0.687	0.0001
BMI	−0.599	0.001	−0.764	0.0001
Waist perimeter	−0.578	0.002	−0.682	0.0001
BSA	0.146	0.47	−0.147	0.48
PASI	−0.010	0.96	−0.305	0.13
NAPSI hands	0.023	0.91	−0.184	0.39
PGA psoriasis	−0.130	0.53	−0.285	0.17
PASE total score	−0.105	0.61	−0.028	0.89
PASE functional	−0.125	0.54	−0.079	0.70
PASE symptoms	−0.080	0.70	0.017	0.94
Adiponectin	−0.077	0.71	−0.489	0.01
Leptin	−0.320	0.11	−0.479	0.01
Resistin	−0.305	0.13	−0.199	0.33
Visfatin	−0.126	0.54	−0.035	0.86
Fat mass (%)	−0.444	0.02	−0.560	0.003

^∗Adjusted for sex, age at the study onset, and disease duration.

Significant results are highlighted in bold.